Surgery, radiotherapy, and chemotherapy in carcinoma of the esophagus

Current Opinion in Gastroenterology

Volumn 16, Issue 4, 2000, Pages 392-399

  Blom, Dennis ^a   Peters, Jeffrey H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN C; PACLITAXEL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE COURSE; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; GASTROESOPHAGEAL REFLUX; HUMAN; LYMPHADENECTOMY; PALLIATIVE THERAPY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0034463058     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200007000-00017     Document Type: Article

References (81)

1. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
2. Barrett's esophagus: A prevalent occult complication of gastroesophageal reflux disease
3. Cancer statistics, 2000
4. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus
5. Hypermethylation of the CDKN2/p16 promoter during neoplastic proliferation in Barrett's esophagus
6. Evolution of neoplastic cell lineages in Barrett oesophagus
7. Chemoprevention of breast cancer
8. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2
9. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence
10. The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability
11. P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients
12. Staging of carcinoma of the esophagus and cardia: A comparison of different staging criteria
13. Esophagogastrectomy for carcinoma of the esophagus and cardia: A comparison of findings and results after standard resection in three consecutive time intervals, using improved staging criteria
14. Staging of esophageal cancer I: Endoscopic ultrasonography
15. Staging esophageal carcinoma II: CT and MRI
16. Value of computed tomography in preoperative evaluation of respectability and staging in esophageal carcinoma
17. Computed tomography for esophageal carcinoma: Its value to the surgeon
18. Combined thoracoscopic/laparoscopic staging of esophageal cancer
19. Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer
20. Endosonographic staging of esophageal cancer: A review of literature results
21. Do we practice what we preach? Clinical decision making and utilization of endoscopic ultrasound for staging esophageal cancer
22. Serial endoscopic ultrasound in the assessment of response to chemoradiotherapy for carcinoma of the esophagus
23. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer
24. Prognostic factors in esophageal squamous carcinoma
25. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma
26. Prognostic factors of resected adenocarcinoma of the esophagus
27. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma
28. Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction
29. The potentially curable cancer of the esophagus
30. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia
31. Surgical therapy for cancer of the esophagus and cardia
32. Endoscopic surveillance of Barrett's esophagus: Does it help?
33. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma
34. Long term survival after photodynamic therapy for esophageal cancer
35. Barrett's esophagus: Photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa and treatment of superficial esophageal cancer
36. Occult esophageal adenocarcinoma: Extent of disease and implications for effective therapy
37. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma
38. The surgical treatment of carcinoma of the oesophagus with special reference to the new operation for growths of the middle third
39. Excision of the thoracic oesophagus for carcinoma, with construction of an extra-thoracic gullet
40. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus
41. Transhiatal esophagectomy: Clinical experience and refinements
42. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: Final report of a phase III multicenter randomized trial
43. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
44. The surgical treatment of carcinoma of the esophagus and cardia
45. En bloc resection for neoplasms of the esophagus and cardia
46. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy
47. En bloc esophagectomy improves survival for stage III esophagus cancer
48. A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer: Updated analysis
49. Result of nationwide study on the three field lymph dissection of esophageal cancer
50. Systemic lymph node dissection for cancer-effective or not?
51. Lymph node metastasis in thoracic esophageal carcinoma
52. How extensive should lymph node dissection be for cancer of the thoracic esophagus?
53. Recurrence of intrathoracic esophageal cancer
54. Extended radical esophagectomy for superficially invasive carcinoma of the esophagus
55. Indications for three field dissection followed by esophagectomy for advanced carcinoma of the thoracic esophagus
56. Results of radical radiotherapy of squamous cell carcinoma of the esophagus
57. Results of radiotherapy for inoperable locally advanced esophageal cancer
58. Radical radiotherapy for carcinoma of the oesophagus: An effective alternative to surgery
59. The quality of swallowing for patients with operable esophageal carcinoma: A randomized trial comparing surgery with radiotherapy
60. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer
61. The value of preoperative radiotherapy in esophageal cancer: Results of a study of the E.O.R.T.C.
62. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial
63. Preoperative radiotherapy for carcinoma of the esophagus
64. Low dose preoperative radiotherapy for carcinoma of the oesophagus: Results of a randomized clinical trial
65. Follow-up results after resection of thoracic esophageal carcinoma
66. Postoperative radiotherapy for carcinoma of the esophagus: A prospective, randomized controlled trial
67. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
68. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study
69. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus
70. A randomized study of radiotherapy alone versus radiotherapy plus 5-Fluorouracil and platinum in patients with operable, locally advanced squamous cell cancer of the esophagus
71. Combined chemotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: A study of the Eastern Cooperative Oncology Group
72. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: A potentially curative approach
73. Combined therapies for squamous cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037)
74. Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma
75. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus
76. Neoadjuvant chemoradiation followed by transhiatal esophagectomy for regional/locally advanced esophageal carcinoma
77. Concurrent chemotherapy (CCT), accelerated fractionated radiation (AFR) and surgery for esophageal cancer
78. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal cancer
79. Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma
80. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
81. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus